Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Frizzled-10

Frizzled-10

Brief Information

Name:Frizzled-10
Target Synonym:Frizzled Class Receptor 10,FZD10,Frizzled 10, Seven Transmembrane Spanning Receptor,Frizzled Family Receptor 10,HFz10,FzE7,Frizzled (Drosophila) Homolog 10,Frizzled Homolog 10 (Drosophila),Frizzled Homolog 10,CD350 Antigen,Frizzled-10,CD350,Fz-10,Fz10
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 1 Clinical

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*
ACRO Quality

Synonym Name

Fz-10, FZD10, hFz10, FzE7, CD350

Background

Frizzled-10 (FZD10) is also known as FzE7 or CD350, which belongs to the G-protein coupled receptor Fz/Smo family. Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. FZD10 contains one FZ (frizzled) domain. FZD10 protein is a cell surface receptor, which is activated by Wnt proteins and involved in the regulation of cellular function. FZD10 interacts with WNT7B and MYOC.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Tabituximab barzuxetan indium In-111 OTSA 101 DTPA-111In; 111IN-OTSA-101 Phase 1 Clinical Oncotherapy Science, Inc Sarcoma, Synovial Details
Tabituximab barzuxetan Yttrium Y-90 OTSA-101; DTPA-90Y Phase 1 Clinical Oncotherapy Science, Inc Sarcoma, Synovial Details
Tabituximab barzuxetan indium In-111 OTSA 101 DTPA-111In; 111IN-OTSA-101 Phase 1 Clinical Oncotherapy Science, Inc Sarcoma, Synovial Details
Tabituximab barzuxetan Yttrium Y-90 OTSA-101; DTPA-90Y Phase 1 Clinical Oncotherapy Science, Inc Sarcoma, Synovial Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message